Back
Emergent BioSolutions Vs. Abbott Laboratories Industry Stock Comparison
Sell
39
EBS
Emergent BioSolutions
Last Price:
9.19
Seasonality Move:
5.89%
Buy
62
ABT
Abbott Laboratories
Last Price:
116.79
Seasonality Move:
2.43%
Sell
39
Emergent BioSolutions (EBS)
is a Sell
Is Emergent BioSolutions a Buy, Sell or Hold?
- The current Emergent BioSolutions [EBS] share price is $8.96. The Score for EBS is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- EBS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Abbott Laboratories (ABT)
is a Buy
Is Abbott Laboratories a Buy, Sell or Hold?
- The current Abbott Laboratories [ABT] share price is $117.73. The Score for ABT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- ABT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EBS Stock Price Chart
What is Emergent BioSolutions's stock price today?
-
The Emergent BioSolutions share price today is $8.96
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EBS is experiencing buying pressure, which is a positive indicator for future bullish movement.
ABT Stock Price Chart
What is Abbott Laboratories's stock price today?
-
The Abbott Laboratories share price today is $117.73
The current trend is moderately bullish and ABT is experiencing slight buying pressure.
EBS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.18 | Buy |
| Relative Strength Index (14 RSI): | 50.4 | Buy |
| Chaikin Money Flow: | 435700 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.75 - 9.47) | Sell |
| Bollinger Bands (100): | (6.85 - 10.77) | Buy |
ABT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.57 | Buy |
| Relative Strength Index (14 RSI): | 56.91 | Buy |
| Chaikin Money Flow: | 1833951 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (113.59 - 117.49) | Buy |
| Bollinger Bands (100): | (105.41 - 115.77) | Buy |
EBS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.18 | Sell |
| 20-day SMA: | 9.14 | Sell |
| 50-day SMA: | 8.34 | Buy |
| 200-day SMA: | 5.95 | Buy |
| 8-day EMA: | 9.09 | Sell |
| 20-day EMA: | 9 | Sell |
| 50-day EMA: | 8.7 | Buy |
| 200-day EMA: | 7.18 | Buy |
ABT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 115.44 | Buy |
| 20-day SMA: | 116.15 | Buy |
| 50-day SMA: | 115.02 | Buy |
| 200-day SMA: | 110.58 | Buy |
| 8-day EMA: | 116.38 | Buy |
| 20-day EMA: | 115.81 | Buy |
| 50-day EMA: | 114.34 | Buy |
| 200-day EMA: | 110.29 | Buy |
Emergent BioSolutions Earnings Growth & EBS Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.20 per share, and an increase next year of $4.66 per share.
Abbott Laboratories Earnings Growth & ABT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $0.48 per share.
Emergent BioSolutions Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Abbott Laboratories Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||